MedWatch

Bavarian Nordic finds buyers for accelerated share offering

Bavarian Nordic announces that the price tag reads DKK 268 (USD 40.7) per share and that buyers have already been found for the accelerated bookbuild, which was announced on Monday.

Photo: Philip Davali/Ekstra Bladet, Philip Davali

Bavarian Nordic has found buyers for the directed issues, which were offered in an accelerated bookbuild, as reported by Bloomberg News.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs